SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.23+0.8%Nov 24 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ibexx who wrote (6408)12/2/1998 10:02:00 PM
From: mauser96  Read Replies (1) of 9523
 
Ibexx...The big bucks are in chronic problems, which by definition last a long time and so need long drug term therapy. If they prove to have minimal GI problems, the Cox2 inhibitors will rapidly take most of the market.
The morbidity and mortality rates of the older NSAID's are quite significant. I'm in the process of being treated for an NSAID complication myself, and I will never touch one of the older ones again.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext